Cardiovascular DiseasesBETTER P2NCT05827718
Testing Promising Behavioral Economic Interventions to Promote Enrollment Diversity in Cardiovascular Cohort Studies
A study testing Method of Contact, Source of Contact and Framing Method (Appeal to Altruism or Social Proof in people with Cardiovascular Diseases, run by University of Pennsylvania at 1 site in United States.
Trial summary
Problem. Randomized clinical trials (RCTs) are the best way to determine if interventions are safe and effective. Usually only a small number of eligible patients enroll. This is because trials require people to consent to be enrolled and randomized. Black and Hispanic people are more likely to develop heart disease. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cardiovascular Diseases
- What is being tested?
- Method of Contact, Source of Contact and Framing Method (Appeal to Altruism or Social Proof
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 26,242 participants
- Where
- 1 siteUnited States
- Study dates
- 30 Oct 2023to 1 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- must have active medical records in site's electronic medical record system.
Who cannot join
- an electronic portal account (e.g. MyPennMedicine)
- have previously been contacted to enroll in the parent trial (e.g. Penn Medicine Biobank)
Trial locations and contacts
1 site in 1 country.
About this study
Problem. Randomized clinical trials (RCTs) are the best way to determine if interventions are safe and effective. Usually only a small number of eligible patients enroll. This is because trials require people to consent to be enrolled and randomized. Black and Hispanic people are more likely to develop heart disease. They are also more likely to have risk factors for heart disease that are not controlled. Yet they are very under-represented in heart disease trials. This raises concerns about if trial results can be applied to the general population. Trial sponsors are required to enroll patients that reflect the racial and ethnic diversity of real-world people. Black and Hispanic people continue to enroll in trials at a lower rate. The goal of this study is to conduct a series of small randomized trials to test recruitment strategies to increase how many Black and Hispanic people enroll in heart disease clinical trials without diminishing trust. The investigators will test different recruitment strategies for participant enrollment in a few different areas. They will study the method of outreach, the way messages are framed, defaults, and enrollment incentives. They will run smaller recruitment strategy trials within larger parent trials (e.g. Penn Medicine Biobank cohort study). They will run a small recruitment strategy trial to test each approach and then include what they learned in the next small trial.
Read the detailed description
Randomized clinical trials (RCTs) are the gold standard for determining the effectiveness and safety of drugs, medical devices, or healthcare delivery interventions. However, because RCTs require participants to consent to enrollment and randomization, typically only a minority of eligible patients enroll, raising concerns regarding the generalizability of trial results. Though Black and Hispanic individuals are disproportionately more likely to have uncontrolled risk factors for cardiovascular disease and to develop cardiovascular disease, they are substantially underrepresented in cardiovascular RCTs. In one review of 143 cardiovascular clinical trials conducted between 2008 and 2017, just 2.1% of enrollees were Black and 2.1% were Hispanic. Such low rates of enrollment have persisted despite mandates by funding and regulatory authorities that trial sponsors aim to enroll patient populations in RCTs that reflect the racial and ethnic diversity of real-world populations of patients with the disease under study. The failure of these recommendations to meaningfully increase the racial and ethnic diversity of RCT participants indicates a need for new and innovative strategies.
Behavioral economics is a scientific field of inquiry that incorporates principles from economics and psychology to better describe how individuals behave and to influence their behavior. While standard economics assumes that individuals are rational expected utility maximizers, behavioral economics recognizes that individuals' decision-making is limited by thinking capacity, available information, and time. As such, decision-making is governed by heuristics, or cognitive shortcuts. For instance, rather than trying to assess the myriad risks and benefits of participating in a research study, individuals may decide not to participate because the invitation to participate isn't from someone whose name they recognize or a perception that people like themselves do not participate. Knowledge of common heuristics can be leveraged to influence choices by modifying the context in which decisions are made, such as by changing default options or how choices are framed. Marketing studies have demonstrated the effectiveness of appeals to altruism, perceived scarcity ("This product is desirable because it is hard to get"), and social proof ("Are people like me using this product or service?") in increasing responsiveness to outreach, and these techniques can be re-purposed to increase representativeness of RCTs. Challenging social circumstances can be thought of as a "tax" on individuals' cognitive bandwidth, underscoring the opportunity to increase RCTs' racial and ethnic diversity by simplifying the enrollment process to make it easier to enroll, increasing the trustworthiness of communications, and reframing participation to make it more attractive.
The reasons for low enrollment of patients from underrepresented racial and ethnic groups in cardiovascular RCTs are multifactorial. Typically, RCTs that enroll vast majorities of patients from global regions with few Black or Hispanic patients will not enroll populations representative of U.S. demographics. Moreover, Black and Hispanic individuals are often less willing than White individuals to participate in RCTs; they are more likely to face barriers in accessing health services and to have mistrust of medical researchers, due to concerns about historic and ongoing scientific misconduct.
Newer means of communication, including patient portals, may increase or decrease representativeness depending on how they are deployed. However, few studies have systematically evaluated recruitment strategies in randomized fashion. As with any intervention, the effectiveness of different recruitment strategies is best assessed by testing different alternatives in RCTs. Accordingly, the overarching goal of this project is to conduct a series of RCTs to rigorously, systematically, and iteratively test strategies designed to increase enrollment of Black and Hispanic individuals in prospective cohort studies without diminishing trust. The investigators will embed RCTs of changes to the decision-making context, or "nudges," in the context of recruitment for prospective cohort studies because these studies' large sample size will facilitate accelerated rapid-cycle testing of multiple nudges, with results from each recruitment RCT incorporated in the next round of testing. Since the nudges are layered on top of existing cohort recruitment methods - changing only the method of outreach, message framing, or incentive structure - they are low cost, and the number of nudges that can be tested is bound primarily by the size of the cohort to be enrolled. The investigative group is uniquely positioned to conduct these studies. First, the investigators have conducted some of the only RCTs evaluating different RCT recruitment strategies. Second, they have established relationships with multiple cohort studies enrolling tens of thousands of patients with cardiovascular diseases. Third, they have extensive experience applying insights from behavioral economics to health behaviors.
The RCTs will sequentially test different strategies for participant enrollment in the following realms: method of outreach, message framing and default settings, and enrollment incentives. The primary outcome of each recruitment RCT will be the enrollment fraction of Black and Hispanic participants - the number of Black and Hispanic patients enrolled divided by the number attempted to be contacted. Because Black and Hispanic populations are heterogeneous, the investigators will also report the effect of each approach on enrollment fraction stratified according to socioeconomic status (SES), assessed using the Area Deprivation Index, a community-level SES metric. Other key secondary outcomes will include the overall enrollment fraction and the population-to-prevalence ratio, defined as the enrollment fraction of Black and Hispanic patients divided by the overall enrollment fraction. Across sequential RCTs of behaviorally-informed recruitment strategies, the investigators will accomplish the following specific aims:
Aim 1. To evaluate the effect of method of outreach on representativeness. First, patients will all receive a message via email (or traditional mail, if no email address is on file) with information about the cohort study and how to enroll and will be randomized to receive an additional message via text message or patient portal. In a subsequent RCT, potential participants will be randomized to receive this message from their personal clinic or from the research team.
Aim 2. To evaluate the effect of message framing on representativeness across two domains - appeal to altruism versus social proof versus neither. The investigators will evaluate the different framing choices in one RCT that will be embedded in an existing large cohort study.
Aim 3. To evaluate different incentive structures on representativeness. We will conduct a five-arm trial to test how incentive structure (no incentive vs. guarantee only vs. guarantee + small lottery vs. mid lottery only vs. large lottery only) affects enrollment fraction of Black and Hispanic patients.
- Conditions
- Cardiovascular Diseases
- Being tested
- Method of Contact, Source of Contact, Framing Method (Appeal to Altruism or Social Proof, Incentive Structure
- Medical subject headings
- Cardiovascular Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Method of ContactBehavioural
Behavioral Intervention studied here is the method of contact (text vs. email vs. email+text).
Source of ContactBehavioural
Behavioral Intervention studied here is source of contact (personal clinic vs. research team)
Framing Method (Appeal to Altruism or Social ProofBehavioural
Behavioral Intervention studied here is the framing methods "appeal to altruism" and "social proof"
Incentive StructureBehavioural
Behavioral Interventions studied here are guaranteed vs. lottery incentives
| Study group | Role | What they receive |
|---|---|---|
| RCT #1, Arm #1: Contact Method, Text Only | Active comparator | Potential participants in the parent trial will be randomized to receive a message via text message. This message will invite them to participate in the parent trial. Receives: Behavioral: Method of Contact |
| RCT #1, Arm #2: Contact Method, Email Only | Active comparator | Potential participants in the parent trial will be randomized to receive a message via email. This message will invite them to participate in the parent trial. Receives: Behavioral: Method of Contact |
| RCT #1, Arm #3: Contact Method, Email+Text | Active comparator | Potential participants in the parent trial will be randomized to receive a message via email and text message. This message will invite them to participate in the parent trial. Receives: Behavioral: Method of Contact |
| RCT #2, Arm #1: Source of Contact, Personal Clinic | Active comparator | Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The sender of the message will be the person's personal clinic. Receives: Behavioral: Source of Contact |
| RCT #2, Arm #2: Source of Contact, Research Team | Active comparator | Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The sender of the message will be the research team. Receives: Behavioral: Source of Contact |
| RCT #3, Arm #1: Framing Method, Appeal to Altruism | Active comparator | Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will appeal to the person's altruism, for example: "Research studies like this one often do not include enough Black individuals. If Black people are not included in research like this, then doctors have less information about how cardiovascular disease might affect them and how new treatments could be used to improve their health. Your participation in this research can help doctors better understand how to treat members of your community in the future." Receives: Behavioral: Framing Method (Appeal to Altruism or Social Proof |
| RCT #3, Arm #2: Framing Method, Social Proof | Active comparator | Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will include language about social proof, i.e. information about participation of individuals similar to the person being contacted. For example, the message will include language such as: "Clinical research studies and the development of effective new medications would not have been possible without the participation of thousands of people like you". Receives: Behavioral: Framing Method (Appeal to Altruism or Social Proof |
| RCT #3, Arm #3: Framing Method, No Appeal to Altruism, No Social Proof | No intervention | Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will include no language about appeal to altruism or social proof. |
| RCT #4, Arm #1: Incentive Structure, No Incentive | No intervention | Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will have no language about incentives. |
| RCT #4, Arm #2: Incentive Structure, Guarantee Only | Active comparator | Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will receive $25. Receives: Behavioral: Incentive Structure |
| RCT #4, Arm #3: Incentive Structure, Guarantee + Small Lottery | Active comparator | Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will receive $15 and have a 1 in 20 chance to receive $200. Receives: Behavioral: Incentive Structure |
| RCT #4, Arm #4: Incentive Structure, Mid Lottery Only | Active comparator | Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will have a 1 in 20 chance to receive $500. Receives: Behavioral: Incentive Structure |
| RCT #5, Arm #5: Incentive Structure, Large Lottery Only | Active comparator | Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will have a 1 in 100 chance to receive $2500. Receives: Behavioral: Incentive Structure |
What is being measured
The primary outcome is the main question the study is designed to answer.
Enrollment fraction of Black + Hispanic patients
The number of Black and Hispanic patients who enroll in the cohort study, divided by the total number of Black and Hispanic patients attempted to be contacted for consideration of enrollment
Measured: three weeks after all attempts have been made to contact is made
Secondary outcomes (6)
Enrollment fraction of Black patients
The number of Black patients who enroll in the cohort study, divided by the total number of Black patients attempted to be contacted for consideration of enrollment
Measured: three weeks after all attempts have been made to contact is made
Enrollment fraction of Hispanic patients
The number of Hispanic patients who enroll in the cohort study, divided by the total number of Hispanic patients attempted to be contacted for consideration of enrollment
Measured: three weeks after all attempts have been made to contact is made
Enrollment fraction by Area Deprivation Index (ADI) quartile
For each ADI quartile, the number of patients who enroll in the cohort study divided by the total number of patients attempted to be contacted for consideration of enrollment
Measured: three weeks after all attempts have been made to contact is made
Overall enrollment fraction
The number of all patients who enroll in the cohort study divided by the total number of all patients attempted to be contacted for consideration of enrollment
Measured: three weeks after all attempts have been made to contact is made
Participation-to-prevalence ratio (PPR) for Black and Hispanic) patients
The percentage of enrolled participants who identify as Black (or Hispanic) patients divided by the percentage of people who identify as Black (or Hispanic) patient in the target population.
Measured: three weeks after all attempts have been made to contact is made
Trust in Medical Researchers Scale
Determined using the Trust in Medical Researchers Scale, a validated 4-item survey to be completed by individuals who decided to enroll in the parent trial. All four items use a 5-point Likert scale and scored accordingly (1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree). The four items that individuals are asked to rank are: (1) Doctors who do medical research care only about what is best for each patient; (2) Doctors tell their patients everything they need to know about being in a research study; (3) Medical researchers treat people like "guinea pigs"; (4) I complete trust doctors who do medical research. The negatively-worded item (#3) is reverse-scored. So higher scores indicate more trust in medical researchers, and lower scores indicate less trust.
Measured: three weeks after all attempts have been made to contact is made
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Apr 2023
- Study start30 Oct 2023
- Primary completion1 Dec 2024
- Study completion1 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Cardiovascular DiseasesStudies of the same condition, open and under way.
- More trials run by University of PennsylvaniaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Sequential
- Model description
- RCT #1: three-arm trial of three methods to contact patients (text v. email v. email+text) / RCT #2: two-arm trial of two sources of contact (personal clinic v. research team) / RCT #3: three-arm trial of framing methods (appeal to altruism vs. appeal to social proof vs. neither) / RCT #4: five-arm trial of incentive structure (no incentive vs. guarantee only vs. guarantee + small lottery vs. mid lottery only vs. large lottery only)
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 26,242 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Pennsylvania
- Sponsor type
- University, hospital or other
- Collaborators
- American Heart Association, Emory University
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05827718
- Sponsor's protocol ID
- 962643
- Acronym
- BETTER P2
- Status last verified
- Jan 2025
- First submitted
- 23 Mar 2023
- Last updated
- 24 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Fanaroff AC, Patel N, Whitman C, Lieberman A, Blady S, Morse Kripke C, Naseer N, Weaver J, Ogunniyi M, Kohn R, Morris AA, Stephens-Shields A, Volpp KG, Halpern SD. Messaging Informed by Behavioral Economics and Representativeness in Clinical Research Enrollment: Four Randomized Clinical Trials. JAMA Netw Open. 2026 Jul 1;9(7):e2622773. doi: 10.1001/jamanetworkopen.2026.22773.
PubMed 42461634
Study at a glance
From the registry record, last updated by the sponsor on 24 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Testing Promising Behavioral Economic Interventions to Promote Enrollment Diversity in Cardiovascular Cohort Studies
- ClinicalTrials.gov ID
- NCT05827718
- Acronym / sponsor ID
- BETTER P2 / 962643
- Conditions
- Cardiovascular Diseases
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 26,242 participants (actual)
- Lead sponsor
- University of PennsylvaniaUniversity, hospital or other
- Collaborators
- American Heart Association, Emory University
- Study start
- 30 Oct 2023 (actual)
- Primary completion
- 1 Dec 2024 (actual)
- Study completion
- 1 Dec 2024 (actual)
- First posted
- 25 Apr 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Problem. Randomized clinical trials (RCTs) are the best way to determine if interventions are safe and effective. Usually only a small number of eligible patients enroll. This is because trials require people to consent to be enrolled and randomized. Black and Hispanic people are more likely to develop heart disease. They are also more likely to have risk factors for heart disease that are not controlled. Yet they are very under-represented in heart disease trials. This raises concerns about if trial results can be applied to the general population. Trial sponsors are required to enroll patients that reflect the racial and ethnic diversity of real-world people. Black and Hispanic people continue to enroll in trials at a lower rate. The goal of this study is to conduct a series of small randomized trials to test recruitment strategies to increase how many Black and Hispanic people enroll in heart disease clinical trials without diminishing trust. The investigators will test different recruitment strategies for participant enrollment in a few different areas. They will study the method of outreach, the way messages are framed, defaults, and enrollment incentives. They will run smaller recruitment strategy trials within larger parent trials (e.g. Penn Medicine Biobank cohort study). They will run a small recruitment strategy trial to test each approach and then include what they learned in the next small trial.
Detailed description
Randomized clinical trials (RCTs) are the gold standard for determining the effectiveness and safety of drugs, medical devices, or healthcare delivery interventions. However, because RCTs require participants to consent to enrollment and randomization, typically only a minority of eligible patients enroll, raising concerns regarding the generalizability of trial results. Though Black and Hispanic individuals are disproportionately more likely to have uncontrolled risk factors for cardiovascular disease and to develop cardiovascular disease, they are substantially underrepresented in cardiovascular RCTs. In one review of 143 cardiovascular clinical trials conducted between 2008 and 2017, just 2.1% of enrollees were Black and 2.1% were Hispanic. Such low rates of enrollment have persisted despite mandates by funding and regulatory authorities that trial sponsors aim to enroll patient populations in RCTs that reflect the racial and ethnic diversity of real-world populations of patients with the disease under study. The failure of these recommendations to meaningfully increase the racial and ethnic diversity of RCT participants indicates a need for new and innovative strategies.
Behavioral economics is a scientific field of inquiry that incorporates principles from economics and psychology to better describe how individuals behave and to influence their behavior. While standard economics assumes that individuals are rational expected utility maximizers, behavioral economics recognizes that individuals' decision-making is limited by thinking capacity, available information, and time. As such, decision-making is governed by heuristics, or cognitive shortcuts. For instance, rather than trying to assess the myriad risks and benefits of participating in a research study, individuals may decide not to participate because the invitation to participate isn't from someone whose name they recognize or a perception that people like themselves do not participate. Knowledge of common heuristics can be leveraged to influence choices by modifying the context in which decisions are made, such as by changing default options or how choices are framed. Marketing studies have demonstrated the effectiveness of appeals to altruism, perceived scarcity ("This product is desirable because it is hard to get"), and social proof ("Are people like me using this product or service?") in increasing responsiveness to outreach, and these techniques can be re-purposed to increase representativeness of RCTs. Challenging social circumstances can be thought of as a "tax" on individuals' cognitive bandwidth, underscoring the opportunity to increase RCTs' racial and ethnic diversity by simplifying the enrollment process to make it easier to enroll, increasing the trustworthiness of communications, and reframing participation to make it more attractive.
The reasons for low enrollment of patients from underrepresented racial and ethnic groups in cardiovascular RCTs are multifactorial. Typically, RCTs that enroll vast majorities of patients from global regions with few Black or Hispanic patients will not enroll populations representative of U.S. demographics. Moreover, Black and Hispanic individuals are often less willing than White individuals to participate in RCTs; they are more likely to face barriers in accessing health services and to have mistrust of medical researchers, due to concerns about historic and ongoing scientific misconduct.
Newer means of communication, including patient portals, may increase or decrease representativeness depending on how they are deployed. However, few studies have systematically evaluated recruitment strategies in randomized fashion. As with any intervention, the effectiveness of different recruitment strategies is best assessed by testing different alternatives in RCTs. Accordingly, the overarching goal of this project is to conduct a series of RCTs to rigorously, systematically, and iteratively test strategies designed to increase enrollment of Black and Hispanic individuals in prospective cohort studies without diminishing trust. The investigators will embed RCTs of changes to the decision-making context, or "nudges," in the context of recruitment for prospective cohort studies because these studies' large sample size will facilitate accelerated rapid-cycle testing of multiple nudges, with results from each recruitment RCT incorporated in the next round of testing. Since the nudges are layered on top of existing cohort recruitment methods - changing only the method of outreach, message framing, or incentive structure - they are low cost, and the number of nudges that can be tested is bound primarily by the size of the cohort to be enrolled. The investigative group is uniquely positioned to conduct these studies. First, the investigators have conducted some of the only RCTs evaluating different RCT recruitment strategies. Second, they have established relationships with multiple cohort studies enrolling tens of thousands of patients with cardiovascular diseases. Third, they have extensive experience applying insights from behavioral economics to health behaviors.
The RCTs will sequentially test different strategies for participant enrollment in the following realms: method of outreach, message framing and default settings, and enrollment incentives. The primary outcome of each recruitment RCT will be the enrollment fraction of Black and Hispanic participants - the number of Black and Hispanic patients enrolled divided by the number attempted to be contacted. Because Black and Hispanic populations are heterogeneous, the investigators will also report the effect of each approach on enrollment fraction stratified according to socioeconomic status (SES), assessed using the Area Deprivation Index, a community-level SES metric. Other key secondary outcomes will include the overall enrollment fraction and the population-to-prevalence ratio, defined as the enrollment fraction of Black and Hispanic patients divided by the overall enrollment fraction. Across sequential RCTs of behaviorally-informed recruitment strategies, the investigators will accomplish the following specific aims:
Aim 1. To evaluate the effect of method of outreach on representativeness. First, patients will all receive a message via email (or traditional mail, if no email address is on file) with information about the cohort study and how to enroll and will be randomized to receive an additional message via text message or patient portal. In a subsequent RCT, potential participants will be randomized to receive this message from their personal clinic or from the research team.
Aim 2. To evaluate the effect of message framing on representativeness across two domains - appeal to altruism versus social proof versus neither. The investigators will evaluate the different framing choices in one RCT that will be embedded in an existing large cohort study.
Aim 3. To evaluate different incentive structures on representativeness. We will conduct a five-arm trial to test how incentive structure (no incentive vs. guarantee only vs. guarantee + small lottery vs. mid lottery only vs. large lottery only) affects enrollment fraction of Black and Hispanic patients.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 13
- Model description
- RCT #1: three-arm trial of three methods to contact patients (text v. email v. email+text) / RCT #2: two-arm trial of two sources of contact (personal clinic v. research team) / RCT #3: three-arm trial of framing methods (appeal to altruism vs. appeal to social proof vs. neither) / RCT #4: five-arm trial of incentive structure (no incentive vs. guarantee only vs. guarantee + small lottery vs. mid lottery only vs. large lottery only)
| Arm | Type | Receives |
|---|---|---|
| RCT #1, Arm #1: Contact Method, Text Only | Active comparator | Behavioral: Method of ContactPotential participants in the parent trial will be randomized to receive a message via text message. This message will invite them to participate in the parent trial. |
| RCT #1, Arm #2: Contact Method, Email Only | Active comparator | Behavioral: Method of ContactPotential participants in the parent trial will be randomized to receive a message via email. This message will invite them to participate in the parent trial. |
| RCT #1, Arm #3: Contact Method, Email+Text | Active comparator | Behavioral: Method of ContactPotential participants in the parent trial will be randomized to receive a message via email and text message. This message will invite them to participate in the parent trial. |
| RCT #2, Arm #1: Source of Contact, Personal Clinic | Active comparator | Behavioral: Source of ContactPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The sender of the message will be the person's personal clinic. |
| RCT #2, Arm #2: Source of Contact, Research Team | Active comparator | Behavioral: Source of ContactPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The sender of the message will be the research team. |
| RCT #3, Arm #1: Framing Method, Appeal to Altruism | Active comparator | Behavioral: Framing Method (Appeal to Altruism or Social ProofPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will appeal to the person's altruism, for example: "Research studies like this one often do not include enough Black individuals. If Black people are not included in research like this, then doctors have less information about how cardiovascular disease might affect them and how new treatments could be used to improve their health. Your participation in this research can help doctors better understand how to treat members of your community in the future." |
| RCT #3, Arm #2: Framing Method, Social Proof | Active comparator | Behavioral: Framing Method (Appeal to Altruism or Social ProofPotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will include language about social proof, i.e. information about participation of individuals similar to the person being contacted. For example, the message will include language such as: "Clinical research studies and the development of effective new medications would not have been possible without the participation of thousands of people like you". |
| RCT #3, Arm #3: Framing Method, No Appeal to Altruism, No Social Proof | No intervention | –Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will include no language about appeal to altruism or social proof. |
| RCT #4, Arm #1: Incentive Structure, No Incentive | No intervention | –Potential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will have no language about incentives. |
| RCT #4, Arm #2: Incentive Structure, Guarantee Only | Active comparator | Behavioral: Incentive StructurePotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will receive $25. |
| RCT #4, Arm #3: Incentive Structure, Guarantee + Small Lottery | Active comparator | Behavioral: Incentive StructurePotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will receive $15 and have a 1 in 20 chance to receive $200. |
| RCT #4, Arm #4: Incentive Structure, Mid Lottery Only | Active comparator | Behavioral: Incentive StructurePotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will have a 1 in 20 chance to receive $500. |
| RCT #5, Arm #5: Incentive Structure, Large Lottery Only | Active comparator | Behavioral: Incentive StructurePotential participants in the parent trial will be randomized to receive a message inviting them to participate in the parent trial. The message will state that, if the person decides to participate, they will have a 1 in 100 chance to receive $2500. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- must have active medical records in site's electronic medical record system.
Key exclusion criteria (2 listed)
- an electronic portal account (e.g. MyPennMedicine)
- have previously been contacted to enroll in the parent trial (e.g. Penn Medicine Biobank)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Method of ContactBehavioral Intervention studied here is the method of contact (text vs. email vs. email+text). | Behavioural | RCT #1, Arm #1: Contact Method, Text Only, RCT #1, Arm #2: Contact Method, Email Only, RCT #1, Arm #3: Contact Method, Email+Text |
| Source of ContactBehavioral Intervention studied here is source of contact (personal clinic vs. research team) | Behavioural | RCT #2, Arm #1: Source of Contact, Personal Clinic, RCT #2, Arm #2: Source of Contact, Research Team |
| Framing Method (Appeal to Altruism or Social ProofBehavioral Intervention studied here is the framing methods "appeal to altruism" and "social proof" | Behavioural | RCT #3, Arm #1: Framing Method, Appeal to Altruism, RCT #3, Arm #2: Framing Method, Social Proof |
| Incentive StructureBehavioral Interventions studied here are guaranteed vs. lottery incentives | Behavioural | RCT #4, Arm #2: Incentive Structure, Guarantee Only, RCT #4, Arm #3: Incentive Structure, Guarantee + Small Lottery, RCT #4, Arm #4: Incentive Structure, Mid Lottery Only, RCT #5, Arm #5: Incentive Structure, Large Lottery Only |
Primary outcome
Enrollment fraction of Black + Hispanic patients
Time frame: three weeks after all attempts have been made to contact is made
The number of Black and Hispanic patients who enroll in the cohort study, divided by the total number of Black and Hispanic patients attempted to be contacted for consideration of enrollment
6 secondary outcomes
Enrollment fraction of Black patients
Time frame: three weeks after all attempts have been made to contact is made
Enrollment fraction of Hispanic patients
Time frame: three weeks after all attempts have been made to contact is made
Enrollment fraction by Area Deprivation Index (ADI) quartile
Time frame: three weeks after all attempts have been made to contact is made
Overall enrollment fraction
Time frame: three weeks after all attempts have been made to contact is made
Participation-to-prevalence ratio (PPR) for Black and Hispanic) patients
Time frame: three weeks after all attempts have been made to contact is made
Trust in Medical Researchers Scale
Time frame: three weeks after all attempts have been made to contact is made
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Jan 2025.
- Derived from this study: PubMed 42461634Fanaroff AC, Patel N, Whitman C, Lieberman A, Blady S, Morse Kripke C, Naseer N, Weaver J, Ogunniyi M, Kohn R, Morris AA, Stephens-Shields A, Volpp KG, Halpern SD. Messaging Informed by Behavioral Economics and Representativeness in Clinical Research Enrollment: Four Randomized Clinical Trials. JAMA Netw Open. 2026 Jul 1;9(7):e2622773. doi: 10.1001/jamanetworkopen.2026.22773.
- Individual participant dataSharing planned: No
Related trials for Cardiovascular Diseases
Active, not recruitingPhase 3
ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
Ischemic Optic Neuropathy
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Not yet recruitingPhase 2
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma (RRMM)
RecruitingPhase 2
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
Multiple Myeloma
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Method of Contact, Source of Contact and Framing Method (Appeal to Altruism or Social Proof in people with Cardiovascular Diseases, run by University of Pennsylvania at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Enrollment fraction of Black + Hispanic patients (time frame: three weeks after all attempts have been made to contact is made). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05827718, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jan 2025.